AKASAKA K 赤坂季代美

Researcher Number	90552753
Other IDs
Affiliation (based on the past Project Information) *help	2013: 岩手医科大学, 医学部, 研究員 2012: 岩手医科大学, 医学部, その他
Review Section/Research Field	Principal Investigator Dermatology
Keywords	Principal Investigator apoptosis / MCL1 / 皮膚腫瘍学 / 抗微小管薬 / BCLxL / BCL2 / 悪性黒色腫

Resistance mechanisms for anti-tubulin agents in malignant melanomasPrincipal Investigator
- Principal Investigator
  
  AKASAKA K
- Project Period (FY)
  2012 – 2013
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Dermatology
- Research Institution
  Iwate Medical University

All 2014 2013 2012

All Journal Article Presentation

[Journal Article] Immunohistochemistry for histone h3 lysine 9 methyltransferase and demethylase proteins in human melanomas.2014
- Author(s)
  Miura S, Maesawa C, Shibazaki M, Yasuhira S, Kasai S, Tsunoda K, Maeda F, Takahashi K, Akasaka T, Masuda T. Immunohistochemistry for histone h3 lysine 9 methyltransferase and demethylase proteins in human melanomas.
- Journal Title
  
  Am J Dermatopathol
  
  Volume: 36(3) Issue: 3 Pages: 211-216
- DOI
  10.1097/dad.0b013e3182964e02
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23590431, KAKENHI-PROJECT-24590489, KAKENHI-PROJECT-24659283, KAKENHI-PROJECT-24791171, KAKENHI-PROJECT-25460421, KAKENHI-PROJECT-25460462, KAKENHI-PROJECT-25860964, KAKENHI-PROJECT-26860891
[Journal Article] BCL2 and BCLxL are key determinants of resistance to antitubulin chemotherapeutics in melanoma cells.2013
- Author(s)
  Watanabe A, Yasuhira S, Inoue T, Kasai S, Shibazaki M, Takahashi K, Akasaka T, Masuda T, Maesawa C.
- Journal Title
  
  Exp Dermatol
  
  Volume: 22(8) Issue: 8 Pages: 518-523
- DOI
  10.1111/exd.12185
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23590431, KAKENHI-PROJECT-24659283, KAKENHI-PROJECT-24791171, KAKENHI-PROJECT-25460462
[Journal Article] Transcriptional and post-transcriptional regulation of βIII-tubulin protein expression in relation with cell cycle-dependent regulation of tumor cells2012
- Author(s)
  Shibazaki M, Maesawa C, Akasaka K, Kasai S, Yasuhira S, Kanno K, Nakayama I, Sugiyama T, Wakabayasi G, Masuda T, Mori N
- Journal Title
  
  Int.J.Oncol.
  
  Volume: 40(3) Pages: 695-702
- DOI
  10.3892/ijo.2011.1291
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22300121, KAKENHI-PROJECT-22390071, KAKENHI-PROJECT-24590489, KAKENHI-PROJECT-24790391, KAKENHI-PROJECT-24791171
[Journal Article] Downregulation of cylindromatosis gene, CYLD, confers a growth advantage on malignant melanoma cells while negatively regulating their migration activity2012
- Author(s)
  Ishikawa Y
- Journal Title
  
  Int J Oncol
  
  Volume: (in press) Issue: 3 Pages: 314-5
- DOI
  10.1111/j.1346-8138.2011.01259.x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390071, KAKENHI-PROJECT-23890198, KAKENHI-PROJECT-24791171
[Presentation] 悪性黒色腫におけるβIII-tubulinの発現とタキサン系抗がん剤感受性に対する影響の解析2012
- Author(s)
  赤坂季代美
- Organizer
  日本病理学会総会
- Place of Presentation
  東京
- Data Source
  KAKENHI-PROJECT-24791171

1. SIBAZAKI Masahiko

# of Collaborated Projects: 0 results

# of Collaborated Products: 3 results
2. 森望

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
3. 増田友之

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
4. 前沢千早

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results

AKASAKA K 赤坂季代美

Research Projects

Research Products

Co-Researchers

Resistance mechanisms for anti-tubulin agents in malignant melanomasPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Immunohistochemistry for histone h3 lysine 9 methyltransferase and demethylase proteins in human melanomas.2014

Author(s)

Journal Title

DOI

Data Source

[Journal Article] BCL2 and BCLxL are key determinants of resistance to antitubulin chemotherapeutics in melanoma cells.2013

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Transcriptional and post-transcriptional regulation of βIII-tubulin protein expression in relation with cell cycle-dependent regulation of tumor cells2012

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Downregulation of cylindromatosis gene, CYLD, confers a growth advantage on malignant melanoma cells while negatively regulating their migration activity2012

Author(s)

Journal Title

DOI

Data Source

[Presentation] 悪性黒色腫におけるβIII-tubulinの発現とタキサン系抗がん剤感受性に対する影響の解析2012

Author(s)

Organizer

Place of Presentation

Data Source

AKASAKA K 赤坂 季代美

Research Projects

Research Products

Co-Researchers

Resistance mechanisms for anti-tubulin agents in malignant melanomasPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Immunohistochemistry for histone h3 lysine 9 methyltransferase and demethylase proteins in human melanomas.2014

Author(s)

Journal Title

DOI

Data Source

[Journal Article] BCL2 and BCLxL are key determinants of resistance to antitubulin chemotherapeutics in melanoma cells.2013

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Transcriptional and post-transcriptional regulation of βIII-tubulin protein expression in relation with cell cycle-dependent regulation of tumor cells2012

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Downregulation of cylindromatosis gene, CYLD, confers a growth advantage on malignant melanoma cells while negatively regulating their migration activity2012

Author(s)

Journal Title

DOI

Data Source

[Presentation] 悪性黒色腫におけるβIII-tubulinの発現とタキサン系抗がん剤感受性に対する影響の解析2012

Author(s)

Organizer

Place of Presentation

Data Source

AKASAKA K 赤坂季代美